PFE Pfizer
too hard · 44
Owner-earnings value$22.55
Price$28.72
Margin of safety
-21.5%
Quality gate · 44/100
⚠ sub-hurdle returns (median roic 7% < 9%) · over-levered (net debt/EBITDA 4.7x > 4x)
Median ROIC7.0%
Gross margin73.2%
Net debt / EBITDA4.7x
FCF conversion101%
Share count / yr+0.4%
Profitable years4/4
Moat & management
Owner-earnings inputs
| Owner earnings (TTM) | 8.50B |
| Owner-earnings yield | 5.2% |
| Free-cash-flow yield | 6.7% |
| Growth used (normalized) | 0.0% |
| Market-implied growth (reverse DCF) | 5.7% |
| Terminal growth | 3.0% |
| Discount rate (hurdle) | 9.0% |
Projected owner earnings
| Yr | Owner earnings | Growth | PV |
|---|---|---|---|
| 1 | 8.50B | 0.0% | 7.80B |
| 2 | 8.53B | 0.3% | 7.18B |
| 3 | 8.59B | 0.7% | 6.63B |
| 4 | 8.67B | 1.0% | 6.14B |
| 5 | 8.79B | 1.3% | 5.71B |
| 6 | 8.93B | 1.7% | 5.33B |
| 7 | 9.11B | 2.0% | 4.98B |
| 8 | 9.32B | 2.3% | 4.68B |
| 9 | 9.57B | 2.7% | 4.41B |
| 10 | 9.86B | 3.0% | 4.17B |
⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Price pays for ~6%/yr owner-earnings growth over 10y (reverse DCF); model credits 0%.